Potential antitumour activity of pasireotide on pituitary tumours in acromegaly  Eva C Coopmans, Aart J van der Lely, Joppe J Schneiders, Sebastian J C.

Slides:



Advertisements
Similar presentations
Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages (June 2012) DOI: /j.tibtech
Advertisements

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target Alexei F. Kisselev, Wouter A. van der Linden, Herman S. Overkleeft Chemistry & Biology.
Recognizing Protein-Ligand Binding Sites by Global Structural Alignment and Local Geometry Refinement Ambrish Roy, Yang Zhang Structure Volume 20, Issue.
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Venezuela: violence, human rights, and health-care realities
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Pharmacogenetics and future drug development and delivery
Cushing's disease  Xavier Bertagna, MD, PhD, Laurence Guignat, MD, Lionel Groussin, MD, PhD, Jérôme Bertherat, MD, PhD  Best Practice & Research Clinical.
Thank God for Richard Dawkins?
Fetal growth and ethnic variation
Sacubitril/valsartan in PARADIGM-HF
Gian Paolo Fadini, Angelo Avogaro  The Lancet Diabetes & Endocrinology 
Meta-analysis of randomised controlled trials
Abdominal lipohypertrophy without insulin injection
Author gender in The Lancet journals
Building neurological services in Africa
Striking cysts: recurrent haematuria in a kickboxer
Understanding EMPA-REG OUTCOME
Physical activity and prevention of type 2 diabetes
Political factors behind US global AIDS programmes slow-down
Aspirin in the prevention of cancer – Author's reply
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Diabetes and risk of physical disability in adults: a systematic review and meta-analysis  Dr Evelyn Wong, MBBS, Kathryn Backholer, PhD, Emma Gearon, BBioMedSc,
Theo Nicholaou, Rachel Wong, Ian D Davis  The Lancet 
Non-surgical treatment of diabetic foot osteomyelitis
Non-uraemic calciphylaxis with acral necrosis
Volume 382, Issue 9906, Pages (November 2013)
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The.
Understanding EMPA-REG OUTCOME
Incident diabetes in clinical trials of antihypertensive drugs
HIV myths should not be resuscitated
Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen 
Effect of development assistance on domestic health expenditures
Striking cysts: recurrent haematuria in a kickboxer
Psychological response and survival in breast cancer
Adrian Martineau  The Lancet Respiratory Medicine 
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Confessions of a journal junkie
Telling it like it isn't: truth and lies in a post-9/11 world
Iran, sanctions, and collaborations
Pituitary siderosis: the dark side of the pituitary
Volume 9, Issue 4, Pages (April 2008)
Multiple endocrine carcinomas of the ileum
Volume 377, Issue 9771, Pages (March 2011)
Thank God for Richard Dawkins?
Low-technology approaches
The emotional journey of gestational diabetes
Does midlife obesity really lower dementia risk?
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
An unusual case of hypopituitarism
Prescription for change
Volume 373, Issue 9672, Pages (April 2009)
Vitamin D status and ill health – Author's reply
Volume 371, Issue 9618, Pages (March 2008)
Sunku H Guptha, Eric Holroyd, Gordon Campbell
Volume 373, Issue 9679, Pages (June 2009)
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Fetal growth and ethnic variation
Volume 368, Issue 9541, Pages (September 2006)
Cholesterol and all-cause mortality in Honolulu
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Political factors behind US global AIDS programmes slow-down
Refining treatment choices for ADHD
Autism, maths, and sex: the special triangle
Reversible biological adaptations in obesity
Presentation transcript:

Potential antitumour activity of pasireotide on pituitary tumours in acromegaly  Eva C Coopmans, Aart J van der Lely, Joppe J Schneiders, Sebastian J C M M Neggers  The Lancet Diabetes & Endocrinology  Volume 7, Issue 6, Pages 425-426 (June 2019) DOI: 10.1016/S2213-8587(19)30113-5 Copyright © 2019 Elsevier Ltd Terms and Conditions

Figure Representative T2-weighted MRI scans from two patients, at baseline and during pasireotide long-acting release (PAS-LAR) treatment Region of interest adenoma to normal pituitary ratio at baseline was 1·05 for patient 1 and 1·34 for patient 2. This signal increased to 1·63 for patient 1 and 1·85 for patient 2 during PAS-LAR treatment. The Lancet Diabetes & Endocrinology 2019 7, 425-426DOI: (10.1016/S2213-8587(19)30113-5) Copyright © 2019 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.